Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab + MTX Structural Efficacy in RA
NCT03535402Phase 3Unknown
- Start
- Jun 2018
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of sarilumab in rheumatoid arthritis (RA). Status: unknown.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03535402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535402.